Cargando…

Clinical and Economic Consequences of Inhaled Corticosteroid Doses and Particle Size in Triple Inhalation Therapy for COPD: Real-Life Study

OBJECTIVE: To determine the clinical and economic consequences of inhaled corticosteroid doses and particle size in patients on triple-inhalation therapy for COPD. METHODS: Patients aged ≥40 years who initiated treatment with multi-inhaler triple-inhaled therapy between 1 January 2015 and 31 March w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sicras-Mainar, Antoni, de Abajo, Francisco J, Izquierdo-Alonso, José Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734046/ https://www.ncbi.nlm.nih.gov/pubmed/33328730 http://dx.doi.org/10.2147/COPD.S281333

Ejemplares similares

Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain
por: Neches García, Victoria, et al.
Publicado: (2022)

Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease
por: Sicras Mainar, Antoni, et al.
Publicado: (2019)

The dose of inhaled corticosteroids in patients with COPD: when less is better
por: Izquierdo, José Luis, et al.
Publicado: (2018)

Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study
por: Sicras-Mainar, Antoni, et al.
Publicado: (2022)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients
por: Darbà, Josep, et al.
Publicado: (2015)

Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD
por: Postma, Dirkje S, et al.
Publicado: (2014)

Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain
por: Miravitlles, Marc, et al.
Publicado: (2022)

Inhaled corticosteroids in COPD and the risk of serious pneumonia
por: Suissa, Samy, et al.
Publicado: (2013)

Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

Rational use of inhaled corticosteroids for the treatment of COPD
por: Quint, Jennifer K., et al.
Publicado: (2023)

“Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD
por: Vogelmeier, Claus, et al.
Publicado: (2017)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
por: Magnussen, Helgo, et al.
Publicado: (2021)

Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
por: Resta, Emanuela, et al.
Publicado: (2022)

Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
por: Avdeev, Sergey, et al.
Publicado: (2019)

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
por: Lutter, Johanna I, et al.
Publicado: (2021)

Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD
por: Shafiek, Hanaa, et al.
Publicado: (2021)

Inhaled Corticosteroids
por: Barnes, Peter J.
Publicado: (2010)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017)

Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysis
por: Flynn, Rob W, et al.
Publicado: (2014)

Clinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in Spain
por: Rodríguez-Quintosa, Jaime, et al.
Publicado: (2022)

Inhaled corticosteroids can reduce osteoporosis in female patients with COPD
por: Liu, Shih-Feng, et al.
Publicado: (2016)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2016)

Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
por: Yawn, Barbara P, et al.
Publicado: (2016)

COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids
por: Ozcakir, Suheda, et al.
Publicado: (2020)

Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2018)

Size of Inhaled Corticosteroid and Small Airway Inflammation in Asthma
por: Park, Choon-Sik
Publicado: (2017)

Current appraisal of single inhaler triple therapy in COPD
por: Lipworth, Brian, et al.
Publicado: (2018)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD
por: Soltani, Amir, et al.
Publicado: (2016)

Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice
por: Cataldo, Didier, et al.
Publicado: (2018)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
por: Oshagbemi, Olorunfemi A., et al.
Publicado: (2018)

Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study
por: Morjaria, Jaymin B., et al.
Publicado: (2017)

Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice
por: van den Bemt, Lisette, et al.
Publicado: (2020)

Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short
por: Tantucci, Claudio, et al.
Publicado: (2020)

Withdrawal of Inhaled Corticosteroids in Patients with COPD – A Prospective Observational Study
por: Nielsen, Anne Orholm, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kvdtp1jtpdqua9t5l44t2ld6u9